vs

Side-by-side financial comparison of Option Care Health, Inc. (OPCH) and StoneX Group Inc. (SNEX). Click either name above to swap in a different company.

Option Care Health, Inc. is the larger business by last-quarter revenue ($1.4B vs $1.2B, roughly 1.1× StoneX Group Inc.). StoneX Group Inc. runs the higher net margin — 11.6% vs 3.4%, a 8.2% gap on every dollar of revenue. On growth, StoneX Group Inc. posted the faster year-over-year revenue change (81.0% vs 1.3%). Over the past eight quarters, StoneX Group Inc.'s revenue compounded faster (53.5% CAGR vs 4.9%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

StoneX Group Inc. is an American financial services company. The company operates in six areas: commercial hedging, global payments, securities, physical commodities, foreign exchange and clearing and execution services (CES).

OPCH vs SNEX — Head-to-Head

Bigger by revenue
OPCH
OPCH
1.1× larger
OPCH
$1.4B
$1.2B
SNEX
Growing faster (revenue YoY)
SNEX
SNEX
+79.7% gap
SNEX
81.0%
1.3%
OPCH
Higher net margin
SNEX
SNEX
8.2% more per $
SNEX
11.6%
3.4%
OPCH
Faster 2-yr revenue CAGR
SNEX
SNEX
Annualised
SNEX
53.5%
4.9%
OPCH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
OPCH
OPCH
SNEX
SNEX
Revenue
$1.4B
$1.2B
Net Profit
$45.3M
$139.0M
Gross Margin
19.4%
Operating Margin
5.4%
15.4%
Net Margin
3.4%
11.6%
Revenue YoY
1.3%
81.0%
Net Profit YoY
-3.0%
63.3%
EPS (diluted)
$0.29
$2.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPCH
OPCH
SNEX
SNEX
Q1 26
$1.4B
Q4 25
$1.5B
$1.2B
Q3 25
$1.4B
$32.7B
Q2 25
$1.4B
$851.2M
Q1 25
$1.3B
$820.4M
Q4 24
$1.3B
$663.1M
Q3 24
$1.3B
$31.1B
Q2 24
$1.2B
$571.8M
Net Profit
OPCH
OPCH
SNEX
SNEX
Q1 26
$45.3M
Q4 25
$58.5M
$139.0M
Q3 25
$51.8M
$85.7M
Q2 25
$50.5M
$63.4M
Q1 25
$46.7M
$71.7M
Q4 24
$60.1M
$85.1M
Q3 24
$53.9M
$76.7M
Q2 24
$53.0M
$61.9M
Gross Margin
OPCH
OPCH
SNEX
SNEX
Q1 26
19.4%
Q4 25
19.3%
Q3 25
19.0%
3.7%
Q2 25
19.0%
Q1 25
19.7%
Q4 24
21.3%
Q3 24
20.1%
3.0%
Q2 24
20.3%
Operating Margin
OPCH
OPCH
SNEX
SNEX
Q1 26
5.4%
Q4 25
6.2%
15.4%
Q3 25
5.9%
0.3%
Q2 25
5.8%
-1.3%
Q1 25
5.9%
-1.0%
Q4 24
6.9%
-3.2%
Q3 24
6.7%
-0.0%
Q2 24
6.6%
-4.7%
Net Margin
OPCH
OPCH
SNEX
SNEX
Q1 26
3.4%
Q4 25
4.0%
11.6%
Q3 25
3.6%
0.3%
Q2 25
3.6%
7.4%
Q1 25
3.5%
8.7%
Q4 24
4.8%
12.8%
Q3 24
4.2%
0.2%
Q2 24
4.3%
10.8%
EPS (diluted)
OPCH
OPCH
SNEX
SNEX
Q1 26
$0.29
Q4 25
$0.37
$2.50
Q3 25
$0.32
$0.72
Q2 25
$0.31
$1.22
Q1 25
$0.28
$1.41
Q4 24
$0.36
$1.69
Q3 24
$0.31
$2.32
Q2 24
$0.30
$1.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPCH
OPCH
SNEX
SNEX
Cash + ST InvestmentsLiquidity on hand
$177.3M
$1.6B
Total DebtLower is stronger
Stockholders' EquityBook value
$2.5B
Total Assets
$3.4B
$47.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPCH
OPCH
SNEX
SNEX
Q1 26
$177.3M
Q4 25
$232.6M
$1.6B
Q3 25
$309.8M
$1.6B
Q2 25
$198.8M
$1.3B
Q1 25
$171.4M
$1.3B
Q4 24
$412.6M
$1.4B
Q3 24
$483.0M
$1.3B
Q2 24
$376.9M
$1.2B
Total Debt
OPCH
OPCH
SNEX
SNEX
Q1 26
Q4 25
Q3 25
$1.2B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.1B
Stockholders' Equity
OPCH
OPCH
SNEX
SNEX
Q1 26
Q4 25
$1.3B
$2.5B
Q3 25
$1.4B
$2.4B
Q2 25
$1.4B
$2.0B
Q1 25
$1.4B
$1.9B
Q4 24
$1.4B
$1.8B
Q3 24
$1.4B
$1.7B
Q2 24
$1.4B
$1.6B
Total Assets
OPCH
OPCH
SNEX
SNEX
Q1 26
$3.4B
Q4 25
$3.5B
$47.8B
Q3 25
$3.5B
$45.3B
Q2 25
$3.4B
$34.3B
Q1 25
$3.3B
$31.3B
Q4 24
$3.4B
$29.6B
Q3 24
$3.4B
$27.5B
Q2 24
$3.3B
$25.9B
Debt / Equity
OPCH
OPCH
SNEX
SNEX
Q1 26
Q4 25
Q3 25
0.86×
Q2 25
0.82×
Q1 25
0.82×
Q4 24
0.79×
Q3 24
0.78×
Q2 24
0.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPCH
OPCH
SNEX
SNEX
Operating Cash FlowLast quarter
$-1.3B
Free Cash FlowOCF − Capex
$-1.3B
FCF MarginFCF / Revenue
-106.4%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
-9.08×
TTM Free Cash FlowTrailing 4 quarters
$3.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPCH
OPCH
SNEX
SNEX
Q1 26
Q4 25
$258.4M
$-1.3B
Q3 25
$139.4M
$3.5B
Q2 25
$90.3M
$1.5B
Q1 25
$-7.2M
$-154.5M
Q4 24
$36.1M
$-477.8M
Q3 24
$160.4M
$192.6M
Q2 24
$195.7M
$-622.1M
Free Cash Flow
OPCH
OPCH
SNEX
SNEX
Q1 26
Q4 25
$-1.3B
Q3 25
$130.2M
$3.5B
Q2 25
$81.2M
$1.5B
Q1 25
$-16.6M
$-169.8M
Q4 24
$25.8M
$-491.4M
Q3 24
$150.7M
$175.9M
Q2 24
$185.9M
$-640.5M
FCF Margin
OPCH
OPCH
SNEX
SNEX
Q1 26
Q4 25
-106.4%
Q3 25
9.1%
10.7%
Q2 25
5.7%
173.3%
Q1 25
-1.2%
-20.7%
Q4 24
2.0%
-74.1%
Q3 24
11.8%
0.6%
Q2 24
15.1%
-112.0%
Capex Intensity
OPCH
OPCH
SNEX
SNEX
Q1 26
Q4 25
1.3%
Q3 25
0.6%
0.1%
Q2 25
0.6%
1.9%
Q1 25
0.7%
1.9%
Q4 24
0.8%
2.1%
Q3 24
0.8%
0.1%
Q2 24
0.8%
3.2%
Cash Conversion
OPCH
OPCH
SNEX
SNEX
Q1 26
Q4 25
4.42×
-9.08×
Q3 25
2.69×
41.18×
Q2 25
1.79×
23.52×
Q1 25
-0.15×
-2.15×
Q4 24
0.60×
-5.61×
Q3 24
2.98×
2.51×
Q2 24
3.69×
-10.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons